APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Incretin-Based Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Incretin-Based Drugs Industry Growth and Trends Forecast to 2032

Report ID 174002390120 December 202599 pages

Choose your research edition.

Industry ResearchIncretin-Based Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Incretin-Based Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Incretin-Based Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Incretin-Based Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Incretin-Based Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Incretin-Based Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Incretin-Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Incretin-Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Incretin-Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Incretin-Based Drugs include Takeda Pharmaceutical Company, Sanofi, Johnson & Johnson, Novartis, Merck & Co, Eli Lilly and Company, GlaxoSmithKline, AstraZeneca and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Incretin-Based Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Incretin-Based Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Incretin-Based Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Incretin-Based Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Incretin-Based Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Incretin-Based Drugs Market by Company

Takeda Pharmaceutical Company

Sanofi

Johnson & Johnson

Novartis

Merck & Co

Eli Lilly and Company

GlaxoSmithKline

AstraZeneca

Boehringer Ingelheim

Incretin-Based Drugs Segment by Type

Glucagon-like peptide-1 receptor (GLP-1) agonists

Dipeptidyl Peptidase-4 (DPP-4) inhibitors

Incretin-Based Drugs Segment by Application

Oral Drugs

Injectable Drugs

Incretin-Based Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Incretin-Based Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Incretin-Based Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Incretin-Based Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Incretin-Based Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Incretin-Based Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Glucagon-like peptide-1 receptor (GLP-1) agonists Table 2. Major Company of Dipeptidyl Peptidase-4 (DPP-4) inhibitors Table 3. Global Incretin-Based Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Incretin-Based Drugs Sales by Type (2021-2026) & (k units) Table 5. Global Incretin-Based Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Incretin-Based Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Incretin-Based Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Incretin-Based Drugs Price by Type (2021-2026) & (US$/unit) Table 9. Global Incretin-Based Drugs Sales by Type (2027-2032) & (k units) Table 10. Global Incretin-Based Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Incretin-Based Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Incretin-Based Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Incretin-Based Drugs Price by Type (2027-2032) & (US$/unit) Table 14. North America Incretin-Based Drugs Sales by Type (2021-2026) & (k units) Table 15. North America Incretin-Based Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Incretin-Based Drugs Sales by Type (2021-2026) & (k units) Table 17. Europe Incretin-Based Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Incretin-Based Drugs Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Incretin-Based Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Incretin-Based Drugs Sales by Type (2021-2026) & (k units) Table 21. Latin America Incretin-Based Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Incretin-Based Drugs Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Incretin-Based Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Incretin-Based Drugs Industry Trends Table 25. Incretin-Based Drugs Industry Drivers Table 26. Incretin-Based Drugs Industry Opportunities and Challenges Table 27. Incretin-Based Drugs Industry Restraints Table 28. Global Incretin-Based Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Incretin-Based Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Incretin-Based Drugs Sales by Company (2021-2026) & (k units) Table 31. Global Incretin-Based Drugs Sales Share by Company (2021-2026) Table 32. Global Incretin-Based Drugs Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Incretin-Based Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Incretin-Based Drugs Major Company Production Sites and Headquarters Table 35. Global Incretin-Based Drugs Company, Product Type & Application Table 36. Global Incretin-Based Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Incretin-Based Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Incretin-Based Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Incretin-Based Drugs Sales by Region (2021-2026) & (k units) Table 41. Global Incretin-Based Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Incretin-Based Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Incretin-Based Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Incretin-Based Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Incretin-Based Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Incretin-Based Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Incretin-Based Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Incretin-Based Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Incretin-Based Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Incretin-Based Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Incretin-Based Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Incretin-Based Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Incretin-Based Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Incretin-Based Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Incretin-Based Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Incretin-Based Drugs Sales by Application (2027-2032) & (k units) Table 57. Global Incretin-Based Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Incretin-Based Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Incretin-Based Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Incretin-Based Drugs Price by Application (2027-2032) & (US$/unit) Table 61. North America Incretin-Based Drugs Sales by Application (2021-2026) & (k units) Table 62. North America Incretin-Based Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Incretin-Based Drugs Sales by Application (2021-2026) & (k units) Table 64. Europe Incretin-Based Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Incretin-Based Drugs Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Incretin-Based Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Incretin-Based Drugs Sales by Application (2021-2026) & (k units) Table 68. Latin America Incretin-Based Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Incretin-Based Drugs Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Incretin-Based Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Pharmaceutical Company Company Information Table 72. Takeda Pharmaceutical Company Business Overview Table 73. Takeda Pharmaceutical Company Incretin-Based Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda Pharmaceutical Company Incretin-Based Drugs Product Portfolio Table 75. Takeda Pharmaceutical Company Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Incretin-Based Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sanofi Incretin-Based Drugs Product Portfolio Table 80. Sanofi Recent Development Table 81. Johnson & Johnson Company Information Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson Incretin-Based Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Johnson & Johnson Incretin-Based Drugs Product Portfolio Table 85. Johnson & Johnson Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Incretin-Based Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Novartis Incretin-Based Drugs Product Portfolio Table 90. Novartis Recent Development Table 91. Merck & Co Company Information Table 92. Merck & Co Business Overview Table 93. Merck & Co Incretin-Based Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Merck & Co Incretin-Based Drugs Product Portfolio Table 95. Merck & Co Recent Development Table 96. Eli Lilly and Company Company Information Table 97. Eli Lilly and Company Business Overview Table 98. Eli Lilly and Company Incretin-Based Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Eli Lilly and Company Incretin-Based Drugs Product Portfolio Table 100. Eli Lilly and Company Recent Development Table 101. GlaxoSmithKline Company Information Table 102. GlaxoSmithKline Business Overview Table 103. GlaxoSmithKline Incretin-Based Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. GlaxoSmithKline Incretin-Based Drugs Product Portfolio Table 105. GlaxoSmithKline Recent Development Table 106. AstraZeneca Company Information Table 107. AstraZeneca Business Overview Table 108. AstraZeneca Incretin-Based Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. AstraZeneca Incretin-Based Drugs Product Portfolio Table 110. AstraZeneca Recent Development Table 111. Boehringer Ingelheim Company Information Table 112. Boehringer Ingelheim Business Overview Table 113. Boehringer Ingelheim Incretin-Based Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Boehringer Ingelheim Incretin-Based Drugs Product Portfolio Table 115. Boehringer Ingelheim Recent Development Table 116. North America Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. North America Incretin-Based Drugs Sales by Country (2021-2026) & (k units) Table 118. North America Incretin-Based Drugs Sales Market Share by Country (2021-2026) Table 119. North America Incretin-Based Drugs Sales Forecast by Country (2027-2032) & (k units) Table 120. North America Incretin-Based Drugs Sales Market Share Forecast by Country (2027-2032) Table 121. North America Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Incretin-Based Drugs Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Incretin-Based Drugs Market Share by Country (2021-2026) Table 124. North America Incretin-Based Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Incretin-Based Drugs Market Share Forecast by Country (2027-2032) Table 126. Europe Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Europe Incretin-Based Drugs Sales by Country (2021-2026) & (k units) Table 128. Europe Incretin-Based Drugs Sales Market Share by Country (2021-2026) Table 129. Europe Incretin-Based Drugs Sales Forecast by Country (2027-2032) & (k units) Table 130. Europe Incretin-Based Drugs Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Incretin-Based Drugs Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Incretin-Based Drugs Market Share by Country (2021-2026) Table 134. Europe Incretin-Based Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Incretin-Based Drugs Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Incretin-Based Drugs Sales by Country (2021-2026) & (k units) Table 138. Asia-Pacific Incretin-Based Drugs Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Incretin-Based Drugs Sales Forecast by Country (2027-2032) & (k units) Table 140. Asia-Pacific Incretin-Based Drugs Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Incretin-Based Drugs Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Incretin-Based Drugs Market Share by Country (2021-2026) Table 144. Asia-Pacific Incretin-Based Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Incretin-Based Drugs Market Share Forecast by Country (2027-2032) Table 146. Latin America Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Latin America Incretin-Based Drugs Sales by Country (2021-2026) & (k units) Table 148. Latin America Incretin-Based Drugs Sales Market Share by Country (2021-2026) Table 149. Latin America Incretin-Based Drugs Sales Forecast by Country (2027-2032) & (k units) Table 150. Latin America Incretin-Based Drugs Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Incretin-Based Drugs Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Incretin-Based Drugs Market Share by Country (2021-2026) Table 154. Latin America Incretin-Based Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Incretin-Based Drugs Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Incretin-Based Drugs Sales by Country (2021-2026) & (k units) Table 158. Middle East and Africa Incretin-Based Drugs Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Incretin-Based Drugs Sales Forecast by Country (2027-2032) & (k units) Table 160. Middle East and Africa Incretin-Based Drugs Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Incretin-Based Drugs Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Incretin-Based Drugs Market Share by Country (2021-2026) Table 164. Middle East and Africa Incretin-Based Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Incretin-Based Drugs Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Incretin-Based Drugs Distributors List Table 169. Incretin-Based Drugs Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Incretin-Based Drugs Image Figure 2. Global Incretin-Based Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Incretin-Based Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Incretin-Based Drugs Sales (2021-2032) & (k units) Figure 5. Glucagon-like peptide-1 receptor (GLP-1) agonists Image Figure 6. Global Glucagon-like peptide-1 receptor (GLP-1) agonists Sales YoY Growth (2021-2032) & (k units) Figure 7. Dipeptidyl Peptidase-4 (DPP-4) inhibitors Image Figure 8. Global Dipeptidyl Peptidase-4 (DPP-4) inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Incretin-Based Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Incretin-Based Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Incretin-Based Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Incretin-Based Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Incretin-Based Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Incretin-Based Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Incretin-Based Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Incretin-Based Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Incretin-Based Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Incretin-Based Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Incretin-Based Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Incretin-Based Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Incretin-Based Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Oral Drugs Image Figure 24. Global Oral Drugs Sales YoY Growth (2021-2032) & (k units) Figure 25. Injectable Drugs Image Figure 26. Global Injectable Drugs Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Incretin-Based Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Incretin-Based Drugs Market Share by Application 2025 VS 2032 Figure 29. North America Incretin-Based Drugs Sales Market Share in Volume by Application in 2025 Figure 30. North America Incretin-Based Drugs Sales Market Share in Value by Application in 2025 Figure 31. Europe Incretin-Based Drugs Sales Market Share in Volume by Application in 2025 Figure 32. Europe Incretin-Based Drugs Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Incretin-Based Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Incretin-Based Drugs Sales Market Share in Value by Application in 2025 Figure 35. Latin America Incretin-Based Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Incretin-Based Drugs Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Incretin-Based Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Incretin-Based Drugs Sales Market Share in Value by Application in 2025 Figure 39. North America Incretin-Based Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Incretin-Based Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Incretin-Based Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Incretin-Based Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Incretin-Based Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Incretin-Based Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Incretin-Based Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Incretin-Based Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Incretin-Based Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Incretin-Based Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Incretin-Based Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Incretin-Based Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Incretin-Based Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Incretin-Based Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Incretin-Based Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Incretin-Based Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Incretin-Based Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Incretin-Based Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Incretin-Based Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Incretin-Based Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Incretin-Based Drugs Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Incretin-Based Drugs Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Glucagon-like peptide-1 receptor (GLP-1) agonists
  • Dipeptidyl Peptidase-4 (DPP-4) inhibitors
Applications
  • Oral Drugs
  • Injectable Drugs
Companies covered
  • Takeda Pharmaceutical Company
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck & Co
  • Eli Lilly and Company
  • GlaxoSmithKline
  • AstraZeneca
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Incretin-Based Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Incretin-Based Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Incretin-Based Drugs Market by Type
  6. 1.3.1 Glucagon-like peptide-1 receptor (GLP-1) agonists
  7. 1.3.2 Dipeptidyl Peptidase-4 (DPP-4) inhibitors
  8. 1.4 Global Incretin-Based Drugs Market Size by Type
  9. 1.4.1 Global Incretin-Based Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Incretin-Based Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Incretin-Based Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Incretin-Based Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Incretin-Based Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Incretin-Based Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Incretin-Based Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Incretin-Based Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Incretin-Based Drugs Industry Trends
  2. 2.2 Incretin-Based Drugs Industry Drivers
  3. 2.3 Incretin-Based Drugs Industry Opportunities and Challenges
  4. 2.4 Incretin-Based Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Incretin-Based Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Incretin-Based Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Incretin-Based Drugs Price (2021-2026)
  4. 3.4 Global Incretin-Based Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Incretin-Based Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Incretin-Based Drugs Company, Product Type & Application
  7. 3.7 Global Incretin-Based Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Incretin-Based Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Incretin-Based Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Incretin-Based Drugs Tier 1, Tier 2, and Tier 3
4 Incretin-Based Drugs Regional Status and Outlook
  1. 4.1 Global Incretin-Based Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Incretin-Based Drugs Historic Market Size by Region
  3. 4.2.1 Global Incretin-Based Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Incretin-Based Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Incretin-Based Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Incretin-Based Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Incretin-Based Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Incretin-Based Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Incretin-Based Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Incretin-Based Drugs by Application
  1. 5.1 Incretin-Based Drugs Market by Application
  2. 5.1.1 Oral Drugs
  3. 5.1.2 Injectable Drugs
  4. 5.2 Global Incretin-Based Drugs Market Size by Application
  5. 5.2.1 Global Incretin-Based Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Incretin-Based Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Incretin-Based Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Incretin-Based Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Incretin-Based Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Incretin-Based Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Incretin-Based Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Incretin-Based Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Company
  2. 6.1.1 Takeda Pharmaceutical Company Company Information
  3. 6.1.2 Takeda Pharmaceutical Company Business Overview
  4. 6.1.3 Takeda Pharmaceutical Company Incretin-Based Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Company Incretin-Based Drugs Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Incretin-Based Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Incretin-Based Drugs Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Incretin-Based Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Incretin-Based Drugs Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Incretin-Based Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Incretin-Based Drugs Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck & Co
  26. 6.5.1 Merck & Co Company Information
  27. 6.5.2 Merck & Co Business Overview
  28. 6.5.3 Merck & Co Incretin-Based Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck & Co Incretin-Based Drugs Product Portfolio
  30. 6.5.5 Merck & Co Recent Developments
  31. 6.6 Eli Lilly and Company
  32. 6.6.1 Eli Lilly and Company Company Information
  33. 6.6.2 Eli Lilly and Company Business Overview
  34. 6.6.3 Eli Lilly and Company Incretin-Based Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly and Company Incretin-Based Drugs Product Portfolio
  36. 6.6.5 Eli Lilly and Company Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Incretin-Based Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Incretin-Based Drugs Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 AstraZeneca
  44. 6.8.1 AstraZeneca Company Information
  45. 6.8.2 AstraZeneca Business Overview
  46. 6.8.3 AstraZeneca Incretin-Based Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AstraZeneca Incretin-Based Drugs Product Portfolio
  48. 6.8.5 AstraZeneca Recent Developments
  49. 6.9 Boehringer Ingelheim
  50. 6.9.1 Boehringer Ingelheim Company Information
  51. 6.9.2 Boehringer Ingelheim Business Overview
  52. 6.9.3 Boehringer Ingelheim Incretin-Based Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Boehringer Ingelheim Incretin-Based Drugs Product Portfolio
  54. 6.9.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Incretin-Based Drugs Sales by Country
  2. 7.1.1 North America Incretin-Based Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Incretin-Based Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Incretin-Based Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Incretin-Based Drugs Market Size by Country
  6. 7.2.1 North America Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Incretin-Based Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Incretin-Based Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Incretin-Based Drugs Sales by Country
  2. 8.1.1 Europe Incretin-Based Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Incretin-Based Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Incretin-Based Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Incretin-Based Drugs Market Size by Country
  6. 8.2.1 Europe Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Incretin-Based Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Incretin-Based Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Incretin-Based Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Incretin-Based Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Incretin-Based Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Incretin-Based Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Incretin-Based Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Incretin-Based Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Incretin-Based Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Incretin-Based Drugs Sales by Country
  2. 10.1.1 South America Incretin-Based Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Incretin-Based Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Incretin-Based Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Incretin-Based Drugs Market Size by Country
  6. 10.2.1 South America Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Incretin-Based Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Incretin-Based Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Incretin-Based Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Incretin-Based Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Incretin-Based Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Incretin-Based Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Incretin-Based Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Incretin-Based Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Incretin-Based Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Incretin-Based Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Incretin-Based Drugs Value Chain Analysis
  2. 12.1.1 Incretin-Based Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Incretin-Based Drugs Production Mode & Process
  7. 12.2 Incretin-Based Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Incretin-Based Drugs Distributors
  10. 12.2.3 Incretin-Based Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst